Advertisement

Antioxidants and Cancer: Molecular Mechanisms

  • Peter J. O’Brien
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 366)

Abstract

Because chemotherapy is often ineffective for the treatment of cancer, considerable efforts are being made to develop agents for “chemoprevention” that would prevent cancers from developing in the first place. Furthermore understanding the antitumorigenic mechanisms should further our comprehension of carcinogenesis mechanisms. In the following, possible molecular mechanisms by which antioxidants inhibit carcinogenesis are reviewed.

Keywords

Polycyclic Aromatic Hydrocarbon Ellagic Acid Propyl Gallate Prostaglandin Synthetase Nordihydroguaiaretic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jaffe, W. The influence of wheat germ oil on the production of tumors in rats by methylcholanthrene. Proc. Soc. Exp. Biol. Med. 111, 714–715 (1946).Google Scholar
  2. 2.
    Haber, S.L. and Wissler, R.W. Effect of vitamin E on carcinogenicity of methylcholanthrene. Proc. Soc. Exp. Biol. Med. 111, 774–775 (1962).Google Scholar
  3. 3.
    Graham, S. Results of case-control studies of diet and cancer in Buffalo, N. Y., Cancer Res. 43, 2409s–2413s (1983).Google Scholar
  4. 4.
    Shamberger, R.J. Relationship of selenium to cancer I inhibitory effect of selenium on carcinogenesis. J. Natl. Cancer Inst. 44, 931–936 (1970).PubMedGoogle Scholar
  5. 5.
    Shamberger, R.J. Increase of peroxidation in carcinogenesis. J. Natl. Cancer Inst. 48, 1491–1497 (1972).PubMedGoogle Scholar
  6. 6.
    Wattenberg, L.W. Inhibition of carcinogenic and toxic effect of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J. Natl. Cancer Inst. 48, 1425–1430 (1972).PubMedGoogle Scholar
  7. 7.
    Hocman, G. Prevention of Cancer: Vegetables and Plants. Comp. Biochem. Physiol. 93B, 201–212 (1989).Google Scholar
  8. 8.
    Block, G., Patterson, B. and Subar, A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Cancer 18, 1–29 (1992).Google Scholar
  9. 9.
    Ames, B.N., Shigenaga, M.K. and Hagen, T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. 90, 7915–7922 (1993).PubMedCrossRefGoogle Scholar
  10. 10.
    Ames, B.N. Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 221, 1256–1264 (1983).PubMedCrossRefGoogle Scholar
  11. 11.
    Morse, M. A. and Stone, G. D. Cancer chemoprevention: principles and prospects. Carcinogenesis 14, 1737–1746 (1993).PubMedCrossRefGoogle Scholar
  12. 12.
    Mukhtar, H., Katiyar, S.K. and Agarwal, R. Green tea and skin-anticarcinogenic effects. J. Inv. Dermatol. 102, 3–7 (1994).CrossRefGoogle Scholar
  13. 13.
    Wattenberg, L.W. Chemoprevention of cancer. Cancer Res. 45, 1–8 (1985).PubMedCrossRefGoogle Scholar
  14. 14.
    Wattenberg, L.W. Inhibition of carcinogenesis by minor anutrient constituents of the diet. Proc. Nutr. Soc. 49, 173–183 (1990).PubMedCrossRefGoogle Scholar
  15. 15.
    Prestera, T., Holtzclaw, W.D., Zhang, Y. and Talalay, P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. 90, 2965–2969 (1993).PubMedCrossRefGoogle Scholar
  16. 16.
    Miller, E.C., Miller, J.A., Brown, R.R. and MacDonald, J.C. On protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and acetylaminofluorene. Cancer Res. 18, 469–473 (1958).PubMedGoogle Scholar
  17. 17.
    Harris, C.C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 262, 1980–1982 (1993).PubMedCrossRefGoogle Scholar
  18. 18.
    Rahimtula, A.D., Zachariah, P.K. and O’Brien, P.J. The effects of antioxidants on the metabolism and mutagenicity of benzo(a)pyrene in vitro. Biochem. J. 164, 473–475 (1977).PubMedGoogle Scholar
  19. 19.
    Rahimtula, A.D., Zachariah, P.K. and O’Brien, P.J. Differential effects of antioxidants on benzo(a)pyrene-3 hydroxylase activity in various tissues of rat. Br. J. Cancer 40, 105–112 (1979).PubMedCrossRefGoogle Scholar
  20. 20.
    Rahimtula, A.D., Jernstrom, B., Dock, L. and Moldeus, P. Effects of dietary and in vitro 2-t butylhydroxyanisole and other phenols on hepatic enzyme activities in mice. Br. J. Cancer. 45, 935–944 (1982).PubMedCrossRefGoogle Scholar
  21. 21.
    Prochaska, H.J. and Talalay, P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48, 4776–4782 (1988).PubMedGoogle Scholar
  22. 22.
    Egner, P.A., Kensler, T.W., Prestera, T., Talalay, P., Libby, A.H. and Curphay, T.J. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinog. 15, 177–181 (1994).CrossRefGoogle Scholar
  23. 23.
    Zhang, Y., Talalay, P., Cho, C.G. and Posner, G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. 89, 2399–2403 (1992).PubMedCrossRefGoogle Scholar
  24. 24.
    Haber, D., Siess, M.H., Waziers, I., Beaune, P. and Suschetet, M. Modification of hepatic drug metabolizing enzymes in rats fed naturally occurring allyl sulfides. Xenobiotica 24, 169–182 (1994).PubMedCrossRefGoogle Scholar
  25. 25.
    Bjeldanes, L.F., Kim, J., Grose, K.R., Bartholomew, J.C. and Bradfield, C.A. Aromatic hydrocarbon responsiveness receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with tetrachlorobenzodioxin. Proc. Natl. Acad. Sci. 88, 9543–9547 (1991).PubMedCrossRefGoogle Scholar
  26. 26.
    Cha, Y. and Heine, H.S. Comparative effects of dietary administration of butylhydroxyanisole and butylhydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res. 42, 2609–2615 (1982).PubMedGoogle Scholar
  27. 27.
    Guo, Z., Smith, T.J., Wang, E., Thomas, P.E. and Yang, C.S. Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic metabolising enzymes and nitrosamine metabolism in rats. Carcinog. 13, 2205–2210 (1992).CrossRefGoogle Scholar
  28. 28.
    Putt, D.A., Kensler, T. and Hollenberg, P. Effects of three chemoprotective antioxidants, ethoxyquin, oltipraz and 1,2 dithiole-3-thione on cytochrome P-450 levels and aflatoxin ß, metabolism. FASEB J. 5, A1517 (1991).Google Scholar
  29. 29.
    Chae, Y., Ho, D.K., Cassady, J.M., Cook, V.M., Craig, B.M. and Baird, W.M. Effects of synthetic and naturally occurring flavonoids on metabolic activation of benzo(a)pyrene in hamster embryo cell cultures. Chem.-Biol. Interacns. 82, 181–193 (1992).CrossRefGoogle Scholar
  30. 30.
    Mukhtar, H. Das, M., Khan, W., Wang, Z.Y., Bik, D.P. and Bickers, D. Exceptional activity of tannic acids among naturally occurring plant phenols in protecting against dimethylbenzanthracene, benzopyrene, 3 methylcholanthrene induced skin tumorigenesis in mice. Cancer Res. 48, 2361–2365 (1988).PubMedGoogle Scholar
  31. 31.
    Verma, A.K., Johnson, J.A., Gould, M.N. and Tanner, M.A. Inhibition of dimethylbenzanthracene and N-nitrosomethylurea induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 48, 5754–5761 (1988).PubMedGoogle Scholar
  32. 32.
    Chae, Y.H., Marcus, C.B., Ho, D.K., Cassady, J.M. and Baird, W.M. Effects of synthetic and naturally occurring flavonoids on benzopyrene metabolism by hepatic microsomes. Cancer Lett. 60, 15–24 (1991).PubMedCrossRefGoogle Scholar
  33. 33.
    Shah, G.M. and Bhattacharya, R.K. Modulation by plant flavonoids and related phenolics of microsome catalysed adduct formation between benzo(a)pyrene and DNA. Chem.-Biol. Interacns. 59, 1–15 (1986).CrossRefGoogle Scholar
  34. 34.
    Siess, N.H. and Vernevaut, M.F. The influence of food flavonoids on the activity of some hepatic microsomal monooxygenases in rats. Fd. Chem. Toxic. 20, 883–886 (1982).CrossRefGoogle Scholar
  35. 35.
    Beyeler, S., Testa, B. and Perrissoud, D. Flavonoids as inhibitors of rat liver monooxy-genase activities. Biochem. Pharmacol. 37, 1971–1979 (1988).PubMedCrossRefGoogle Scholar
  36. 36.
    Steele, C.M., Lalies, M. and Ioannides, C. Inhibition of the mutagenicity of aromatic amines by the plant flavonoid(+)-catechin. Cancer Res. 45, 3573–3577 (1985).PubMedGoogle Scholar
  37. 37.
    Das, M., Khan, W.A., Asokan, P., Bickers, D.R. and Mukhtar, H. Inhibition of epidermal xenobiotic metabolism in mice by naturally occurring plant phenols. Cancer Res. 47, 760–766 (1987).PubMedGoogle Scholar
  38. 38.
    Chang, R.L., Huang, M.T., Wood, A.W., Wong, C.Q., Newmark, H.L., Yagi, H., Sayer, J.M., Jerina, D.M. and Conney, A.H. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo(a)pyrene on mouse skin. Carcinog. 6, 1127–1133 (1985).CrossRefGoogle Scholar
  39. 39.
    Sayer, J.M., Whalen, D.L. and Jerina, D.M. Chemical strategies for the inactivation of bayregion diol epoxides. Drug. Metab. Rev. 20, 155–182 (1989).PubMedCrossRefGoogle Scholar
  40. 40.
    Zhang, Z., Hamilton, S.M., Stewart, C., Strothers, A. and Teel, R.W. Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco specific nitrosamine NNK by ellagic acid. Anticancer Res. 13, 2341–2346 (1993).PubMedGoogle Scholar
  41. 41.
    Das, M., Bickers, D.R. and Mukhtar, H. Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action. Carcinog. 6, 1409–1413 (1985).CrossRefGoogle Scholar
  42. 42.
    Agarwal, R., Wang, Z.Y., Bik, D.P. and Mukhtar, H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P450 mediated monooxygenase activity. Drug Metab. Disp. 19, 620–624 (1991).Google Scholar
  43. 43.
    Yang, C.S. and Strickhart, F.S. Inhibition of hepatic mixed function oxidase activity by propyl gallate. Biochem. Pharmacol. 23, 3129–3138 (1974).PubMedCrossRefGoogle Scholar
  44. 44.
    Hong, J., Wang, Z., Smith, T.J., Zhou, S., Shi, S., Pan, J. and Yang, C.S. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco specific carcinogen 4-(methylnitrosamino)-l-(3 pyridyl)-l-butanone in A/J mouse lung. Carcinogenesis 13, 901–904 (1992).PubMedCrossRefGoogle Scholar
  45. 45.
    Liu, L. and Castonguay, A. Inhibition of the metabolism and genotoxicity of 4 methyl-nitrosamino pyridyl butanone in rat hepatocytes by catechin. Carcinog. 12, 1203–1208 (1991).CrossRefGoogle Scholar
  46. 46.
    Castonguay, A., Allaire, L., Charest, M., Rossignol, G., and Boutet, M. Metabolism of methylnitrosamino-l-(3 pyridyl)-1 butanone by hamster respiratory tissues cultured with ellagic acid. Cancer Lett., 46, 93 (1989); for errata, see 47, 161.PubMedCrossRefGoogle Scholar
  47. 47.
    Barch, D.H. and Fox, C.C. Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine. Cancer Lett. 44, 39–44 (1989).PubMedCrossRefGoogle Scholar
  48. 48.
    You, W., Blot, W., Chang, A.E., Yang, Z.T., Qi, A., Henderson, B.E., Fraumeni, J.F., Wang, T. Allium vegetables and reduced risk of stomach cancer. JNCI 81, 162–164 (1989).PubMedCrossRefGoogle Scholar
  49. 49.
    Pan, J., Hong, J.Y., Ma, B.L., Ning, S.M., Paranawithana, S.R. and Yang, C.S. Transcriptional activation of cytochrome P450 2B1/2 genes in rat liver by diallyl sulfide, a compound derived from garlic. Arch. Biochem. Biophys. 302, 337–342 (1993).PubMedCrossRefGoogle Scholar
  50. 50.
    Vang, O., Jensen, H. and Autrup, H. Induction of cytochrome P450 1A1, 1A2, 2B1, 2B2 and 2E1 by broccoli in rat liver and colon. Chem. Biol. Interacns. 78, 85–96 (1991).CrossRefGoogle Scholar
  51. 51.
    Wortelboer, H.M., De Kruif, C.A., Iersel, A.A., Noordhoek, J., Blaauboer, B., Van Bladeren, P.J. and Falke, H.E. Effects of cooked brussel sprouts on cytochrome P450 profile and phase II enzymes in rat. Fd. Chem. Toxic. 30, 17–27 (1992).CrossRefGoogle Scholar
  52. 52.
    Ishizaki, H., Brady, J.F., Ning, S.M. and Yang, C.S. Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine metabolism and other monooxygenase activities. Xenobiotica 20, 255–264 (1990).PubMedCrossRefGoogle Scholar
  53. 53.
    Salbe, A.D., and Bjeldanes, L.F. Effect of diet on the DNA binding of aflatoxin B1 in the rat. Carcinogenesis 10, 629–634 (1989).PubMedCrossRefGoogle Scholar
  54. 54.
    Tanaka, T., Mori, Y., Morishita, Y., Hara, A., Ohno, T., Kojima, T. and Mori, H. Inhibitory effect of sinigrin and indolecarbinol on diethylnitrosamine-induced hepatocarcinogenesis in male rats. Carcinogenesis 11, 1403–1406 (1990).PubMedCrossRefGoogle Scholar
  55. 55.
    Wortelboer, H.M., Kruif, C.A., Falke, H.E., Noordhoek, J. and Blaauboer, B.J. Acid reacton products of indole carbinol and their effects on cytochrome P450 and phase II enzymes in hepatocytes. Biochem. Pharmacol. 43, 1439–1447 (1992).PubMedCrossRefGoogle Scholar
  56. 56.
    Wattenberg, L.W. and Bueding, E. Inhibitory effects of oltipraz on carcinogenesis induced by benzo(a)pyrene and diethylnitrosamine. Carcinogenesis 7, 1379–1381 (1986).PubMedCrossRefGoogle Scholar
  57. 57.
    Kensler, T.W., Groopman, J.D., Eaton, D.L., Curphey, T. and Roebuck, B. Potent inhibition of aflatoxin induced hepatic tumorigenesis by the monofuctional enzyme inducer 1,2 dithiole-3-thione. Carcinogenesis 13, 95–100 (1992).PubMedCrossRefGoogle Scholar
  58. 58.
    Eling, T.E. and Curtis, J.F. Hydroperoxide-dependent oxidation. Pharmacol. Ther. 53, 261 (1993).CrossRefGoogle Scholar
  59. 59.
    Sarkar, F.H., Radcliff, G. and Callewaert, D.M. Purified prostaglandin synthase activates aromatic amines to mutagenic derivatives. Mutn. Res. 282, 273–281 (1992).CrossRefGoogle Scholar
  60. 60.
    Pruess-Schwartz, D., Nimesheim, A. and Marnett, L.J. Peroxyl radical and cytochrome P-450 metabolic activation of 7,8 dihydroxy 7,8 dihydrobenzo(a)pyrene in mouse skin in vitro and in vivo. Cancer Res. 49, 1732–1737 (1989).PubMedGoogle Scholar
  61. 61.
    Zenser, T.V. and Davis, B.B. Arachidonic acid metabolism by human urothelial cells: implications in aromatic amine-induced bladder cancer. Prostaglandins Leuk. Essent. Fatty Acids: Rev. 31: 199–207 (1988).Google Scholar
  62. 62.
    Yamazoe, Y., Zenser, T.V., Miller, D.W. and Kadlubar, F.F. Mechanism of formation and structural characterisation of DNA adducts derived from peroxidative activation of benzidine. Carcinogen. 9, 1635–1641 (1988).CrossRefGoogle Scholar
  63. 63.
    Krauss, R.S., Angerman-Stewart, J., Dooley, K.L., Kadlubar, F.F. and Eling, T.E. The formation of 2 aminofluorene-DNA in vivo: evidence for peroxidase-mediated activation. Biochem. Toxicol. 4, 111–117 (1989).CrossRefGoogle Scholar
  64. 64.
    Josephy, P.D., Chiu, A.I.H. and Eling, T.E. Prostaglandin H synthase dependent mutagenic activation of benzidine in a Styphimunium Ames tester strain possesing elevated N-acetyltransferase levels Cancer Res. 49, 853–856 (1989).PubMedGoogle Scholar
  65. 65.
    Majid, S., Kharduja, K., Gandhi, R.K., Kapus, S. and Sharma, R.R. Influence of ellagic acid on antioxidant defense system and lipid peroxidation in mice. Biochem. Pharmacol. 42, 1441–1445 (1991).PubMedCrossRefGoogle Scholar
  66. 66.
    Marnett, L.J., Reed, G.A. and Johnson, J.T. Prostaglandin synthetase dependent benzo(a)pyrene oxidation: products of the oxidation and inhibition of their formation by antioxidants. Biochem. biophys. Res. Comm. 79, 569–576 (1977).PubMedCrossRefGoogle Scholar
  67. 67.
    O’Brien, P.J. Radical formation during the peroxidase catalyzed metabolism of carcinogens and xenobiotics: the reactivity of these radicals with GSH, DNA and unsaturated lipid. Free Radic. Biol. Med. 4, 169–183 (1988).PubMedCrossRefGoogle Scholar
  68. 68.
    Tsuruta, Y., Subrahmanyan, V.V., Marshall, W. and O’Brien, P.J. Peroxidase mediated irreversible binding of aryamine carcinnogens to DNA in intact polymorphonuclear leukocytes activated by a tumor promoter. Chemico-Biol. Interacns. 53, 25–35 (1985).CrossRefGoogle Scholar
  69. 69.
    Uetrecht, J.P. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab. Rev. 24, 299–366 (1992).PubMedCrossRefGoogle Scholar
  70. 70.
    Cross, A.R. Inhibitors of the leukocyte superoxide generating oxidase. Free Rad. Biol. Med. 8, 71–93 (1990).PubMedCrossRefGoogle Scholar
  71. 71.
    Chena, K.C., Cahill, D.S., Kasai, H., Nishimura, S., and Loeb, L.A. 8 hydroxydeoxy-guanosine, an abundant form of oxidative DNA damage causes G-T and A-T substitution. J. Biol. Chem. 267, 166–172 (1992).Google Scholar
  72. 72.
    Kensler, T. W., Bush, D.M. and Kozumbo, W.J. Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 221, 75–77 (1983).PubMedCrossRefGoogle Scholar
  73. 73.
    Kasai, H., Okada, Y., Nishimura, S., Rao, M.S., and Reddy, J.K. Formation of 8-hydroxydeoxyguanosine in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate. Carcinogenesis 11, 345–347 (1989).Google Scholar
  74. 74.
    Hinrichsen, L.I., Floyd, R.A. and Sudilovsky, O. Is 8 hydroxydeoxyguanosine a mediator of carcinogenesis by choline-devoid diet in the rat liver? Carcinogenesis 11, 1879–1881 (1990).PubMedCrossRefGoogle Scholar
  75. 75.
    Kasai, H., Nishimura, S., Kurokawa, Y., and Hayoslii, Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis, 8, 1959–1961 (1987).PubMedCrossRefGoogle Scholar
  76. 76.
    Umemura, T., Sai, K., Takagi, A., Hasegawa, R. and Kurokawa, Y. Formation of 8-hydroxydeoxyguanosine in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate. Carcinogenesis 11, 345–347 (1990).PubMedCrossRefGoogle Scholar
  77. 77.
    Tchou, J., and Grollman, A.P. Repair of DNA containing the oxidatively damaged base, 8 oxyguanine. Mutn. Res. 299, 277–287 (1993).CrossRefGoogle Scholar
  78. 78.
    Slaga, T.J., Fischer, S.M., Weeks, C.E., Nelson, K., Mamrack, M. and Klein-Szanto, A.J.P. Specificity and mechanism(s) of promoter inhibitors in multistage promotion. In: Carcinogenesis, Vol. 7, pp. 19–34, Hecker, E., Kuntz, W., Fusenig, N.E., Marks, F. and Thielmann, H.W. (eds) Raven Press, New York (1982).Google Scholar
  79. 79.
    Athar, M., Raza, H., Bickers, D.M. and Muktar, H. Inhibition of benzoyl peroxide mediated tumor promotion in 1,2 dimethylbenz(a)anthracene-initiated skin of Sencar mice by antioxidants, nordihydroguaiaretic acid and diallyl sulfide. J. Invest. Dermatol., 94, 162 (1990).PubMedCrossRefGoogle Scholar
  80. 80.
    Huang, M.T., Smart, R.C., Wong, C.Q., Conney, A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, ferulic acid on tumor promotion in mouse skin by tetradecanoylphorbol acetate. Cancer Res. 48, 5941–5946 (1988).PubMedGoogle Scholar
  81. 81.
    Rao, M.S., Lalwani, N.D., Watanabe, T.K. and Reddy, J.K. Inhibitory effects of antioxidants ethoxyquin and butylhydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res. 44, 1072–1076 (1984).PubMedGoogle Scholar
  82. 82.
    Ghoshal, A.K., Rushmore, T.H., Calderon, P., Roberfroid, M. and Farber, E. Prevention by a free radical scavenger of prooxidant effects of choline deficiency. Free Rad. Biol. Med. 8, 3–7 (1990).PubMedCrossRefGoogle Scholar
  83. 83.
    Okada, S., Hamazaki, S., Ebina, Y., Li, J.L. and Midorikawa, O. Nephrotoxicity and its prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation. Biochim. biophys. Acta 922, 28–33 (1987).PubMedCrossRefGoogle Scholar
  84. 84.
    Tanaka, T., Kojima, T., Kawamori, T., Wang, A., Suzui, M., Okamoto, K. and Mori, H. Inhibition of 4 nitroquinoline 1 oxide induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14, 1321–1325 (1993).PubMedCrossRefGoogle Scholar
  85. 85.
    Nunoshiba, T., and Demple, B. Potent intracellular oxidative stress exerted by the carcinogen 4 nitroquinoline N oxide. Cancer Res. 53, 3250–3252 (1993).PubMedGoogle Scholar
  86. 86.
    Wargowich, M. J., Imada, O. and Stephens, L.C. Initiation and post initiation chemopreventive effects of diallyl sulfide in oesophageal carcinogenesis. Cancer Lett. 64, 39–42 (1992).CrossRefGoogle Scholar
  87. 87.
    Cerutti, P.A. Oxidant stress and carcinogenesis. Eur. J. Clin. Invest. 21, 1–5 (1991).PubMedCrossRefGoogle Scholar
  88. 88.
    Keller, B.J., Marsman, D.S.O., Popp, J.A., Thyman, R.G. Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation. Biochim. biophys. Acta 1162, 237 (1992).CrossRefGoogle Scholar
  89. 89.
    Monteiro, H.P., Ivaschenko, Y., Fischer, R. and Stern, A. Inhibition of protein tyrosine phosphatase activity by diamide is reversed by epidermal growth factor in fibroblasts. FEBS Lett. 295, 146–148 (1991).PubMedCrossRefGoogle Scholar
  90. 90.
    Milo, G.E., Kurican, P., Kirsten, E. and Kun, E. Inhibition of carcinogen-induced cellular transformation of human fibroblasts by drugs that interact with the poly(ADP-ribose) polymerase system. FEBS Lett. 179, 332–336 (1985).PubMedCrossRefGoogle Scholar
  91. 91.
    Yamamoto, S. and Kyoto, R. Inhibitors of the arachidonic acid cascade and their chemoprevention of skin cancer, in Cancer Chemoprevention. Ed Wattenberg, L., Lipkin, M., Boone, C.W. and Keloff, G.J. pp 141–151, CRC press (1992).Google Scholar
  92. 92.
    Marnett, L.J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52, 5575–5589 (1992).PubMedGoogle Scholar
  93. 93.
    Reddy, B.S. Inhibitors of the arachidonic acid cascade and their chemoprevention of colon carcinogenesis, in Cancer Chemoprevention. Ed. Wattenberg, L., Lipkin, M., Boone, C.W. and Kelopff, G.J. pp. 153–163, CRC Press (1992).Google Scholar
  94. 94.
    Nguyen, T. and Pickett, C.B. Regulation of rat glutathione S transferase Ya subunit gene expression. J. Biol. Chem. 267, 1535–13539 (1992).Google Scholar
  95. 95.
    Prestera, T., Holtzclaw, Zhang, Y. and Talalay, P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. 90, 2965–2969 (1993).PubMedCrossRefGoogle Scholar
  96. 96.
    Li, Y. and Jaiswal, A.K. Regulation of human NAD(P)H: quinone oxidoreductase gene: role of AP1 binding site contained within human antioxidant responsive element. J. Biol. Chem. 267, 15097–15104 (1992).PubMedGoogle Scholar
  97. 97.
    Prestera, T., Zhang, Y., Spencer, S.R., Wilczak, C.A. and Talalay, P. The electrophile counterattack response: protection against neoplasia and toxicity. Adv. Enz. Regul. 33, 281–296 (1993).CrossRefGoogle Scholar
  98. 98.
    DeLong, M.J., Dolan, P., Santamaria, A. and Bueding, E. Dithiolethione analogs: effects on NAD(P)H quinone reductase and glutathione levels in murine hepatoma cells. Carcinog. 7, 977–980 (1986).CrossRefGoogle Scholar
  99. 99.
    Morel, F., Fardel, O., Meyer, D.J., Kensler, T.W., Ketterer, B. and Guillouzo, A. Preferential increase of GS transferase class α-transcripts in cultured human hepatocytes by phenobarbital, methylcholanthrene and dithiolethiones. Cancer Res. 53, 231–234 (1993).PubMedGoogle Scholar
  100. 100.
    Munday, R. and Winterbourn, C.C. Reduced glutathione in combination with superoxide dismutase as an important biological antioxidant defense mechanism. Biochem. Pharmacol. 38, 4349–4352 (1989).PubMedCrossRefGoogle Scholar
  101. 101.
    Keyse, S.M. and Tyrrell, R.M. Both near ultraviolet radiation and the oxidising agent hydrogen peroxide induced a 32KDa stress protein in normal human skin fibroblasts. J. Biol. Chem. 262, 14821–14825 (1987).PubMedGoogle Scholar
  102. 102.
    Cantoni, A., Guidarelli, O., Sestili, P., Mannello, F., Gazzanelli, G. and Cattabeni, F. Development and characterization of hydrogen peroxide resistant Chinese hamster ovary cell variants. Biochem. Pharmacol. 45, 2251–2257 (1993).PubMedCrossRefGoogle Scholar
  103. 103.
    Spitz, D.R., Adams, D.T., Sherman, C.M. and Roberts, R.J. Mechanisms of cellular resistance to hydrogen peroxide, hyperoxia and 4 hydroxy 2 nonenal toxicity: the significance of increased catalase activity in H2O2 resistant fibroblasts. Arch. Biochem. Biophys. 292, 221–227 (1992).PubMedCrossRefGoogle Scholar
  104. 104.
    Spitz, D.R., Sullivan, S.J., Malcom, R.R., and Roberts, R.J. Glutathione dependent metabolism and detoxification of 4 hydroxy 2 nonenal. Free Rad. Biol. Med. 11, 415–423 (1991).PubMedCrossRefGoogle Scholar
  105. 105.
    Chu, F.F., Esworthy, R.S., Aleman, S. and Dorshow, J.H. Modulation of glutathione peroxidase expression by selenium. Nucl. Acid. Res. 18, 1531–1539 (1990).CrossRefGoogle Scholar
  106. 106.
    Sandstrom, B., Carlsson, J. and Marklund, S.L. Selenite-induced variation in glutathione peroxidase activity of three mammalian cell lines. Radiation Res. 117, 318–325 (1989).PubMedCrossRefGoogle Scholar
  107. 107.
    Bannai, S., Sato, H., Ishii, T. and Taketani, S. Enhancement of glutathione levels in mouse peritoneal macrophages. Biochim. biophys. Acta. 1092, 175–179 (1991)PubMedCrossRefGoogle Scholar
  108. 108.
    Deneke, S.M. and Fanburg, B.L. Regulation of cellular glutathione Am. J. Physiol. 257, L163–L173 (1989).PubMedGoogle Scholar
  109. 109.
    Taketani, S., Sato, H., Yoshinaga, T., Tokunaga, R., Ishii, T., and Bannai, S. Induction in mouse peritoneal macrophages of 34kDa stress protein and heme oxygenase by sulfhydryl-reactive agents. J. Biochem. 108, 111–115 (1990).Google Scholar
  110. 110.
    Mimnaugh, E.G., Dusre, L., Atwell, J. and Myers, C.E. Differential oxygen radical susceptibility of adriamycin-sensitive and-resistant human breast tumor cells. Cancer Res. 49, 8–15 (1989).PubMedGoogle Scholar
  111. 111.
    Sinha, B.K., Minnaugh, E.C., Rajagopalan, S. and Myers, C.E. Adriamycin activation and oxygen free radical formation in human breast tumor cells. Cancer Res. 49, 3844–3848 (1989).PubMedGoogle Scholar
  112. 112.
    Meier-Bratschi, A., Lutz, W.K. and Schlatter, C. Methylation of liver DNA of a rat and mouse by N-nitrosodimethylamine formed in vivo from dimethylamine and nitrite. Food Chem. Toxicol. 21, 285–290 (1983).PubMedCrossRefGoogle Scholar
  113. 113.
    Astili, B.D. and Mulligan, L.T. Phenolic antioxidants and the inhibition of hepatotoxicity from N-dimethylnitrosamine formed in situ in the rat stomach. Fd. Cosmet. Toxicol. 15, 167–171 (1977).CrossRefGoogle Scholar
  114. 114.
    Stich, H.F., Dunn, B.P., Pignatelli, B., Ohshinia, H. and Bartsch, H. Dietary phenolics and betel nut extracts as modifiers of N-nitrosation in rat and man. IARC Sc. Publ. 57, 213–222 (1984).Google Scholar
  115. 115.
    Pignatelli, B., Bereziat J., Descotes, G. and Bartsch, H. Catalysis of nitrosation in vivo in rats by catechin and resorcinol and inhibition by chlorogenic acid. Carcinogenesis 3, 1045–1049 (1982).PubMedCrossRefGoogle Scholar
  116. 116.
    Kuenzig W., Chan, J., Norkus, E., Newmark, H., Mergens, W. and Conney, A.H. Caffeic acid and ferulic acid as blockers of nitrosamine formation. Carcinogenesis 5, 309–313 (1984).PubMedCrossRefGoogle Scholar
  117. 117.
    Nguyen, T., Brunson, D., Crespi, C.L., Periman, B.W., Wishnok, J.S. and Tannenbaum, S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. 89, 3030–3034 (1992).PubMedCrossRefGoogle Scholar
  118. 118.
    Carreras, M.C., Paragament, G.A., Catz, S.D., Poderoso, J.J. and Boveris, A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiration burst of human neutrophils. FEBS Lett. 341, 65–68 (1994).PubMedCrossRefGoogle Scholar
  119. 119.
    Michnovicz, J.J., Bradlow, H.L. Induction of estradiol metabolism by dietary indole-1-carbinol in humans. J. Natl. Cancer Inst. 82, 947–949 (1990).PubMedCrossRefGoogle Scholar
  120. 120.
    Baldwin, W.S. and Leblanc, G.A. The anticarcinogenic plant compound indolecarbinol differentially modulates P450-mediated steroid hydroxylase activities in mice. Chem.-Biol. Interacns. 83, 155–169 (1992).CrossRefGoogle Scholar
  121. 121.
    Bradlow, H.L., Michnovicz, J.J., Telang, N.T. and Osborne, M.P. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12, 1571–1574 (1991).PubMedCrossRefGoogle Scholar
  122. 122.
    Takahashi, S., Hakoi, K., Yaga, H., Hirose, M., Ito, N. and Fukushima, S. Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis 13, 1513–1518 (1992).PubMedCrossRefGoogle Scholar
  123. 123.
    Bailey, G.S., Hendricks, J.D., Shelton, D.W. Enhancement of carcinogenesis by the natural anticarcinogenindole-3-carbinol. J. Natl. Cancer Inst. 78, 931–934 (1987).PubMedGoogle Scholar
  124. 124.
    Ito, N. and Hirose, M. Antioxidants-carcinogenic and chemopreventive properties. Adv. Cancer Res. 53, 247–302 (1989).PubMedCrossRefGoogle Scholar
  125. 125.
    Farber, E. Clonal adaptation during carcinogenesis. Biochem. Pharmacol. 39, 1837–1846 (1990).PubMedCrossRefGoogle Scholar
  126. 126.
    Jones, G.R.N. Cancer destruction in vivo through disrupted energy metabolism. Physiol. Chem. Phys. and Med. NMR 24, 181–194 (1992).Google Scholar
  127. 127.
    De Vries, C.E. and Van Noorden, C.J.F. Effects of fatty acids on tumor growth and metastasis. Anticancer Res. 12, 1513–1522 (1992).PubMedGoogle Scholar
  128. 128.
    Corrocher, R., Casaril, M., Bellisola, G., Gabrielli, G.B., Guidi, G.C. and DeSandre, G. Severe impairment of antioxidant systems in human hepatoma. Cancer 58, 1658–1662 (1986).PubMedCrossRefGoogle Scholar
  129. 129.
    Canuto, R.A.,, Muzio, G., Biocca, M.E. and Dianzani, M.U. Lipid peroxidation in rat AH-130 hepatoma cells enriched in vitro with arachidonic acid. Cancer Res. 51, 4603–4608 (1991).PubMedGoogle Scholar
  130. 130.
    Cogrel, P., Morel, I., Lescoat, G., Chevanne, M., Brissot, P., Cillard, P. and Cillard, J. The relationship between fatty acid peroxidation and α-tocopherol consumption in isolated normal and transformed hepatocytes. Lipids 28, 115–119 (1993).PubMedCrossRefGoogle Scholar
  131. 131.
    Kandaswami, C., Perkins, E., Soloniuk, D.S. and Middleton, E. Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblastlike lung cells in culture by plant flavonoids. Anti-Cancer Drugs 3, 525–530 (1992).PubMedCrossRefGoogle Scholar
  132. 132.
    Khan, S., Ramuvani, J.J. and O’Brien, P.J. The toxicity of mechlorethamine and other alkylating anti-cancer drugs: role of lipid peroxidation. Biochem. Pharmacol. 43, 1963–1967 (1992).PubMedCrossRefGoogle Scholar
  133. 133.
    Powis, G. and Hacker, M.P. The toxicity of anticancer drugs. Pergamon Press (1991).Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Peter J. O’Brien
    • 1
  1. 1.Faculty of PharmacyUniversity of TorontoTorontoCanada

Personalised recommendations